Trials / Completed

CompletedNCT00163631

Relationship of Vasoactive Peptide Levels to Portal Pressure and Patient Outcomes in Patients With Hepatic Cirrhosis

Status: Completed
Phase: —
Study type: Observational
Enrollment: —

Sponsor: Bayside Health · Other Government
Sex: All
Age: 18 Years – 70 Years
Healthy volunteers: Not accepted

Summary

Investigate vasoactive medicators in portal hypertension on stored sera

Conditions

Portal Hypertension

Timeline

First posted: 2005-09-14
Last updated: 2006-10-04

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT00163631. Inclusion in this directory is not an endorsement.

Relationship of Vasoactive Peptide Levels to Portal Pressure and Patient Outcomes in Patients With Hepatic Cirrhosis (NCT00163631) · Clinical Trials Directory